<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105831">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01833962</url>
  </required_header>
  <id_info>
    <org_study_id>001-3708</org_study_id>
    <nct_id>NCT01833962</nct_id>
  </id_info>
  <brief_title>A Retrospective Study of Actifuse Synthetic Bone Graft Versus Other Bone Graft Substitutes in Patients Requiring Lumbar Fusion</brief_title>
  <official_title>A Retrospective Study of Actifuse Synthetic Bone Graft Versus Other Bone Graft Substitutes in Patients Requiring Lumbar Fusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OrthoGeorgia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>OrthoGeorgia</source>
  <oversight_info>
    <authority>Baxter Healthcare:  Deerfield, IL. United States</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess fusion status in patients who underwent spinal fusion
      with Actifuse synthetic bone graft versus other bone graft material (including autograft) in
      achieving lumbar spinal fusion.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Achievement of fusion prior to or at 12 months postoperatively</measure>
    <time_frame>6 - 12 months year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lumbar Fusion</condition>
  <arm_group>
    <arm_group_label>Actifuse</arm_group_label>
    <description>Patients who recieved Actifuse synthetic bone brafting material</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All study patients will be extracted from our current patient population. A total of 50
        patients treated with Actifuse and 50 patients treated with other synthetic bone grafting
        substitutes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any patient 18 years of age or older

          -  Patients with a minimum follow up of 1 year

          -  Patients who have previously undergone TLIF, PLIF,PLF, XLIF procedures

        Exclusion Criteria:

          -  Patients under the age of 18

          -  Any patient with less than 1 year of follow up history at the time of first data
             analysis

          -  Any patient that the primary investigator deems as an unfit candidate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William B Dasher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physician</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Craig C Odum</last_name>
    <phone>478-254-5377</phone>
    <email>codum@orthoga.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>OrthoGeorgia</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig C Odum</last_name>
      <phone>478-254-5377</phone>
      <email>codum@orthoga.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.orthoga.org</url>
  </link>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 16, 2013</lastchanged_date>
  <firstreceived_date>April 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lumbar fusion rates</keyword>
  <keyword>Actifuse synthetic bone graft</keyword>
  <keyword>Baxter Healthcare</keyword>
  <keyword>Other synthetic bone graft</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
